Physicians, Pharmaceutical Sales Representatives, and the Cost of Prescribing

Archives of Family Medicine

Volumn 5, Issue 4, 1996, Pages 201-206

  Caudill, T Shawn ^a,d   Johnson, Mitzi S ^b   Rich, Eugene C ^a   McKinney, W Paul ^c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATTITUDE TO HEALTH; CLINICAL PRACTICE; DRUG INDUSTRY; DRUG INFORMATION; ECONOMICS; EMPIRICAL APPROACH; FEE; FEMALE; GENERAL PRACTITIONER; HEALTH CARE AND PUBLIC HEALTH; HEALTH PERSONNEL ATTITUDE; HUMAN; MALE; MIDDLE AGED; PRESCRIPTION; QUESTIONNAIRE; REGRESSION ANALYSIS; UNITED STATES; UTILIZATION REVIEW;

EMPIRICAL APPROACH; HEALTH CARE AND PUBLIC HEALTH;

ATTITUDE OF HEALTH PERSONNEL; DRUG INDUSTRY; DRUG INFORMATION SERVICES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; KENTUCKY; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY; PRESCRIPTION FEES; PRESCRIPTIONS, DRUG; QUESTIONNAIRES; REGRESSION ANALYSIS;

EID: 0030116133     PISSN: 10633987     EISSN: None     Source Type: Journal    
DOI: 10.1001/archfami.5.4.201     Document Type: Article

References (18)

1. Chren MM, Landfeld CS, Murray TH. Doctors, drug companies and gifts. JAMA. 1989;262:3448-3451.
2. Rawlins MD. Doctors and the drug makers. Lancet. 1984;2:276-278.
3. Miller K, Couveia WA, Barza M, et al. Undesirable marketing practices in the pharmaceutical industry. N Engl J Med. 1985;313:54.
4. Hemminki E. Review of the literature on the factors affecting drug prescribing. Soc Sci Med. 1975;9:111-116.
5. Holland AE. Representatives and advertisements as sources of information. Postgrad Med J. 1977;53:559-561.
6. Eaton G, Parish P. Sources of drug information used by general practitioners. J R Coll Gen Pract. 1976;26:58-64.
7. Stross JK. Information sources and clinical decisions. J Gen Intern Med. 1987; 2:155-159.
8. Becker WIH, Stolley PD, Lasagna L, McEvilla JD, Sloane LM. Correlates of physicians' prescribing behavior. Inquiry. 1972;9:30-42.
9. Connelly DP, Rich EC, Curley SP, Kelly JT. Knowledge resource preferences of family physicians. J Fam Pract. 1990;30:353-359.
10. McKinney WP, Schendermayer DL, Lurie N, Simpson DE, Goodman JL, Rich EC. Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives. JAMA. 1990;264:1693-1697.
11. Sifton DW, ed. Drug Topics Red Book. Montvale, NJ: Medical Economics Data; 1992.
12. Ethics Committee for the American College of Physicians. Physicians and the pharmaceutical industry. Ann Intern Med. 1990;112:624-626.
13. Council on Ethical and Judicial Affairs of the American Medical Association. Gifts to physicians from industry. JAMA. 1991;265:501.
14. Working Party for the Royal College of Physicians. The relationship between physicians and the pharmaceutical industry. J R Coll Phys. 1986;20:235-242.
15. Eaton G, Parish P. General practitioners' views of information about drugs. J R Coll Gen Pract. 1976;26:64-68.
16. Bowen AD, Burkett GL. Family physicians and generic drugs: a study of recognition, information sources, prescribing attitudes, and practices. J Fam Pract. 1987;24:612-616.
17. Fassold RW, Gowdey GW: A survey of physicians' reactions to drug promotion. Can Med Assoc J. 1968;98:701-705.
18. Avorn J, Chen M, Hartley R. Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med. 1982;73:4-8.